These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
951 related articles for article (PubMed ID: 15824256)
1. Progressive gray matter damage in patients with relapsing-remitting multiple sclerosis: a longitudinal diffusion tensor magnetic resonance imaging study. Oreja-Guevara C; Rovaris M; Iannucci G; Valsasina P; Caputo D; Cavarretta R; Sormani MP; Ferrante P; Comi G; Filippi M Arch Neurol; 2005 Apr; 62(4):578-84. PubMed ID: 15824256 [TBL] [Abstract][Full Text] [Related]
2. Determinants of disability in multiple sclerosis at various disease stages: a multiparametric magnetic resonance study. Pulizzi A; Rovaris M; Judica E; Sormani MP; Martinelli V; Comi G; Filippi M Arch Neurol; 2007 Aug; 64(8):1163-8. PubMed ID: 17698707 [TBL] [Abstract][Full Text] [Related]
3. Short-term accrual of gray matter pathology in patients with progressive multiple sclerosis: an in vivo study using diffusion tensor MRI. Rovaris M; Gallo A; Valsasina P; Benedetti B; Caputo D; Ghezzi A; Montanari E; Sormani MP; Bertolotto A; Mancardi G; Bergamaschi R; Martinelli V; Comi G; Filippi M Neuroimage; 2005 Feb; 24(4):1139-46. PubMed ID: 15670691 [TBL] [Abstract][Full Text] [Related]
4. In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study. Agosta F; Absinta M; Sormani MP; Ghezzi A; Bertolotto A; Montanari E; Comi G; Filippi M Brain; 2007 Aug; 130(Pt 8):2211-9. PubMed ID: 17535835 [TBL] [Abstract][Full Text] [Related]
5. Diffusion-tensor magnetic resonance imaging detects normal-appearing white matter damage unrelated to short-term disease activity in patients at the earliest clinical stage of multiple sclerosis. Gallo A; Rovaris M; Riva R; Ghezzi A; Benedetti B; Martinelli V; Falini A; Comi G; Filippi M Arch Neurol; 2005 May; 62(5):803-8. PubMed ID: 15883269 [TBL] [Abstract][Full Text] [Related]
6. Magnetization transfer magnetic resonance imaging and clinical changes in patients with relapsing-remitting multiple sclerosis. Oreja-Guevara C; Charil A; Caputo D; Cavarretta R; Sormani MP; Filippi M Arch Neurol; 2006 May; 63(5):736-40. PubMed ID: 16682543 [TBL] [Abstract][Full Text] [Related]
7. Gray matter atrophy in multiple sclerosis: a longitudinal study. Fisher E; Lee JC; Nakamura K; Rudick RA Ann Neurol; 2008 Sep; 64(3):255-65. PubMed ID: 18661561 [TBL] [Abstract][Full Text] [Related]
8. Evidence for progressive gray matter loss in patients with relapsing-remitting MS. Valsasina P; Benedetti B; Rovaris M; Sormani MP; Comi G; Filippi M Neurology; 2005 Oct; 65(7):1126-8. PubMed ID: 16217074 [TBL] [Abstract][Full Text] [Related]
9. Intra-voxel and inter-voxel coherence in patients with multiple sclerosis assessed using diffusion tensor MRI. Cercignani M; Bozzali M; Iannucci G; Comi G; Filippi M J Neurol; 2002 Jul; 249(7):875-83. PubMed ID: 12140672 [TBL] [Abstract][Full Text] [Related]
10. Conventional and magnetization transfer MRI predictors of clinical multiple sclerosis evolution: a medium-term follow-up study. Rovaris M; Agosta F; Sormani MP; Inglese M; Martinelli V; Comi G; Filippi M Brain; 2003 Oct; 126(Pt 10):2323-32. PubMed ID: 12937086 [TBL] [Abstract][Full Text] [Related]
11. [Diffusion tensor imaging of the normal-appearing brain tissue in relapsing-remitting multiple sclerosis]. Yu CS; Li KC; Lin FC; Jiang TZ; Sun H; Chen B Zhonghua Yi Xue Za Zhi; 2006 May; 86(18):1260-4. PubMed ID: 16796886 [TBL] [Abstract][Full Text] [Related]
12. Diffusion-weighted MR of the brain: methodology and clinical application. Mascalchi M; Filippi M; Floris R; Fonda C; Gasparotti R; Villari N Radiol Med; 2005 Mar; 109(3):155-97. PubMed ID: 15775887 [TBL] [Abstract][Full Text] [Related]
13. TI-relaxation time changes over five years in relapsing-remitting multiple sclerosis. Papadopoulos K; Tozer DJ; Fisniku L; Altmann DR; Davies G; Rashid W; Thompson AJ; Miller DH; Chard DT Mult Scler; 2010 Apr; 16(4):427-33. PubMed ID: 20086026 [TBL] [Abstract][Full Text] [Related]
14. Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study. Tedeschi G; Dinacci D; Comerci M; Lavorgna L; Savettieri G; Quattrone A; Livrea P; Patti F; Morra VB; Servillo G; Orefice G; Paciello M; Prinster A; Coniglio G; Bonavita S; Di Costanzo A; Bellacosa A; Valentino P; Quarantelli M; Brunetti A; Salemi G; D'Amelio M; Simone I; Salvatore M; Bonavita V; Alfano B Mult Scler; 2009 Feb; 15(2):204-11. PubMed ID: 18987104 [TBL] [Abstract][Full Text] [Related]
15. White matter and lesion T1 relaxation times increase in parallel and correlate with disability in multiple sclerosis. Parry A; Clare S; Jenkinson M; Smith S; Palace J; Matthews PM J Neurol; 2002 Sep; 249(9):1279-86. PubMed ID: 12242554 [TBL] [Abstract][Full Text] [Related]
16. Occult tissue damage in patients with primary progressive multiple sclerosis is independent of T2-visible lesions--a diffusion tensor MR study. Rocca MA; Iannucci G; Rovaris M; Comi G; Filippi M J Neurol; 2003 Apr; 250(4):456-60. PubMed ID: 12700912 [TBL] [Abstract][Full Text] [Related]
17. Influence of aging on brain gray and white matter changes assessed by conventional, MT, and DT MRI. Benedetti B; Charil A; Rovaris M; Judica E; Valsasina P; Sormani MP; Filippi M Neurology; 2006 Feb; 66(4):535-9. PubMed ID: 16505308 [TBL] [Abstract][Full Text] [Related]
18. MRI relapses have significant pathologic and clinical implications in multiple sclerosis. Traboulsee A J Neurol Sci; 2007 May; 256 Suppl 1():S19-22. PubMed ID: 17346748 [TBL] [Abstract][Full Text] [Related]